Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells

Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene

(2010) Y. Zhao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase

(2010) N. Ji et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Transcriptional suppression of breast cancer resistance protein (BCRP) by wild-type p53 through the NF-κB pathway in MCF-7 cells

(2010) Xuedong Wang et al.   FEBS LETTERS

Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin

(2010) S Wang et al.   ONCOGENE

Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

(2009) J. Lu et al.   CLINICAL CANCER RESEARCH

HER2,TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

(2009) Bent Ejlertsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Differential gene expression profiling of human epidermal growth factor receptor 2-overexpressing mammary tumor

(2008) Yan Wang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer

(2008) Jianhui Yuan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer

(2008) Helen M. Coley   CANCER TREATMENT REVIEWS

Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway

(2007) Byeong Hyeok Choi et al.   CANCER LETTERS